Cargando…

Role of Senescence in Tumorigenesis and Anticancer Therapy

Although the role of senescence in many physiological and pathological processes is becoming more identifiable, many aspects of senescence are still enigmatic. A special attention is paid to the role of this phenomenon in tumor development and therapy. This review mainly deals with a large spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoczynska-Fidelus, Ewelina, Węgierska, Marta, Kierasińska, Amelia, Ciunowicz, Damian, Rieske, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956409/ https://www.ncbi.nlm.nih.gov/pubmed/35342397 http://dx.doi.org/10.1155/2022/5969536

Ejemplares similares

Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene
por: Włodarczyk, Aneta, et al.
Publicado: (2022)

Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy
por: Tręda, Cezary, et al.
Publicado: (2023)

EGFR(vIII): An Oncogene with Ambiguous Role
por: Rutkowska, Adrianna, et al.
Publicado: (2019)

Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells
por: Wlodarczyk, Aneta, et al.
Publicado: (2020)

Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy
por: Grot, Dagmara, et al.
Publicado: (2022)

SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence
por: Winiecka-Klimek, Marta, et al.
Publicado: (2015)

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors
por: Walczak, Maciej P., et al.
Publicado: (2016)

The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2014)

A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells – possible approaches to circumvent these phenomena
por: Janik, Karolina, et al.
Publicado: (2019)

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
por: Drozd, Anna M., et al.
Publicado: (2015)

Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line
por: STOCZYNSKA-FIDELUS, EWELINA, et al.
Publicado: (2016)

Efficient and simple approach to in vitro culture of primary epithelial cancer cells
por: Janik, Karolina, et al.
Publicado: (2016)

Different mutational characteristics of TSG in cell lines and surgical specimens
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2014)

EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line
por: Treda, Cezary, et al.
Publicado: (2016)

IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis
por: Rosiak, Kamila, et al.
Publicado: (2016)

Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation
por: Stec, Wojciech, et al.
Publicado: (2018)

Cell line with endogenous EGFR(vIII) expression is a suitable model for research and drug development purposes
por: Stec, Wojciech J., et al.
Publicado: (2016)

Low Incidence along with Low mRNA Levels of EGFR(vIII) in Prostate and Colorectal Cancers Compared to Glioblastoma
por: Peciak, Joanna, et al.
Publicado: (2017)

Limited importance of the dominant-negative effect of TP53 missense mutations
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2011)

Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes
por: Smyczynska, Urszula, et al.
Publicado: (2022)

PIN3 duplication may be partially responsible for TP53 haploinsufficiency
por: Winiecka-Klimek, Marta, et al.
Publicado: (2014)

Targeting senescence as an anticancer therapy
por: Bousset, Laura, et al.
Publicado: (2022)

Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
por: Bieńkowski, Michał, et al.
Publicado: (2013)

Exploiting tumor cell senescence in anticancer therapy
por: Lee, Minyoung, et al.
Publicado: (2014)

Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
por: Piaskowski, S, et al.
Publicado: (2011)

The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
por: Jaganjac, Morana, et al.
Publicado: (2020)

The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023)

The Yin-Yang of DNA Damage Response: Roles in Tumorigenesis and Cellular Senescence
por: Li, Xiaoman, et al.
Publicado: (2013)

Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
por: Piskorz, Wiktoria Monika, et al.
Publicado: (2022)

Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
por: Witusik-Perkowska, Monika, et al.
Publicado: (2010)

The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis
por: Valenzuela, Claudio A., et al.
Publicado: (2017)

Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis
por: De Blander, Hadrien, et al.
Publicado: (2021)

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
por: Prasanna, Pataje G, et al.
Publicado: (2021)

Correction to: Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Publicado: (2022)

Targeting anticancer drug-induced senescence in glioblastoma therapy
por: Tomicic, Maja T., et al.
Publicado: (2018)

The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
por: Sisay, Mekonnen, et al.
Publicado: (2017)

Stress induced premature senescence : a new culprit in ovarian tumorigenesis?
por: Raghuram, Gorantla Venkata, et al.
Publicado: (2014)

The out-of-field dose in radiation therapy induces delayed tumorigenesis by senescence evasion
por: Goy, Erwan, et al.
Publicado: (2022)

The emerging role of WISP proteins in tumorigenesis and cancer therapy
por: Liu, Yi, et al.
Publicado: (2019)

The emerging role of SPOP protein in tumorigenesis and cancer therapy
por: Song, Yizuo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6fq9s7pa53rq81l7s3t73plsih